2021
DOI: 10.1001/jamapsychiatry.2020.4418
|View full text |Cite
|
Sign up to set email alerts
|

Interpreting the Findings of a Meta-analysis of Psychosocial Interventions in Bipolar Disorder

Abstract: His spouse is a former employee at Eli Lilly (1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013). No other disclosures were reported.1. Miklowitz DJ, Efthimiou O, Furukawa TA, et al. Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis. JAMA Psychiatry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…The lack of difference between BD, BSp and uMDD groups in therapy response suggests that these widely available therapies could be appropriate for people with BD. More broadly, the effectiveness of psychological therapies for BD is reflected by prioritisation in clinical guidelines (NICE, 2020 ) despite concerns about the risk of bias in the evidence (Tong, Strawbridge, & Jauhar, 2021 ). IAPT pilot programmes have recently been trialled for people with SMI, but despite efforts made to address the low rates of therapy access for severely ill people (Jones et al, 2018 ), it is not yet known how widely this will be available.…”
Section: Discussionmentioning
confidence: 99%
“…The lack of difference between BD, BSp and uMDD groups in therapy response suggests that these widely available therapies could be appropriate for people with BD. More broadly, the effectiveness of psychological therapies for BD is reflected by prioritisation in clinical guidelines (NICE, 2020 ) despite concerns about the risk of bias in the evidence (Tong, Strawbridge, & Jauhar, 2021 ). IAPT pilot programmes have recently been trialled for people with SMI, but despite efforts made to address the low rates of therapy access for severely ill people (Jones et al, 2018 ), it is not yet known how widely this will be available.…”
Section: Discussionmentioning
confidence: 99%